By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences has sold certain patent applications covering molecular diagnostic applications of its technology to Sequenom for $1.3 million, the firm disclosed in a filing with the US Securities and Exchange Commission yesterday after the close of the market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.